• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 61-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
AEK-0832720-3/1/1 02-Apr-2013 61CIA01 3006611753 Sha Medicines Health Products Ie Co China
 
AEK-0834642-7/1/1 02-Apr-2013 61CIA01 3006611753 Sha Medicines Health Products Ie Co China
 
XXX-0180737-5/1/1 17-Apr-2013 61EA08 3003299706 Schering Plough Belgium
 
AEK-0867963-7/2/2 03-Apr-2013 61EDY08 3010034650 Minisrty Of Ptt Saudi Arabia
 
112-1582578-3/1/1 15-Apr-2013 61GRR47 3008617115 Zhejiang Guobang Pharm Co., Ltd China
 
M21-0747910-9/1/1 05-Apr-2013 61HAB43 3005144955 Chemo S.A. Lugano Branch Switzerland
 
112-1910006-8/1/1 04-Apr-2013 61HCZ14 3010059559 Sun Industries India
 
112-2171833-7/1/1 16-Apr-2013 61HMC99 3002693205 Vetoquinol N.A., Inc. Canada
 
M21-0747910-9/2/1 05-Apr-2013 61JAA14 3005144955 Chemo S.A. Lugano Branch Switzerland
 
UPS-0110320-1/1/6 19-Apr-2013 61JCA08 3010075631 Natasha Darville Bahamas
 
UPS-0110320-1/1/11 19-Apr-2013 61LCY38 3010075631 Natasha Darville Bahamas
 
UPS-0256503-6/1/1/B 12-Apr-2013 61MAY11 3007479796 Dr. Clark Research Associates United States
 
UPS-0125062-2/1/1 03-Apr-2013 61NCA73 3006490869 Greenstone, Ltd. United States
 
UPS-0057881-7/1/2 03-Apr-2013 61PAC26 3010060344 Farouma Iporahim Canada
 
AEK-0868076-7/1/1 02-Apr-2013 61PBH99 3010034823 Maxo Laboratories P Ltd India
 
AEK-0803344-7/2/2 29-Apr-2013 61PCA31 3010098963 Iayeshbhai Shah India
 
112-2137308-3/3/1 11-Apr-2013 61PCA55 3002807504 Merck Sante s.a.s France
 
112-2137308-3/4/1 11-Apr-2013 61PCA99 3004159855 Hik Pha Jordan
 
AEK-0803344-7/2/1 29-Apr-2013 61PCP62 3010098963 Iayeshbhai Shah India
 
112-2137308-3/1/1 10-Apr-2013 61PDA99 3004758118 Merck & Co Inc United States
 
XXX-0180737-5/1/2 17-Apr-2013 61WQA47 3009327342 Stada-Vn Jv Co., Ltd Vietnam
 
-
-